Perspective Therapeutics (CATX) Non Operating Income (2010 - 2026)

Perspective Therapeutics has disclosed Non Operating Income across 17 years of filings, most recently posting $2.3 million for Q2 2026.

• In Q2 2026, Non Operating Income rose 11.52% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $10.1 million (down 15.62% YoY), while the FY2025 annual figure was $9.1 million, down 12.65% from the prior year.
• Non Operating Income came in at $2.3 million for Q2 2026 at Perspective Therapeutics, up from $2.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.7 million in Q1 2025 to a low of $29000.0 in Q1 2022.
• Average Non Operating Income over 5 years is $1.4 million, with a median of $870500.0 recorded in 2022.
• Year-over-year, Non Operating Income tumbled 94.12% in 2023 and soared 8136.36% in 2024.
• Over 5 years, Non Operating Income stood at $561000.0 in 2022, then plunged by 94.12% to $33000.0 in 2023, then soared by 8136.36% to $2.7 million in 2024, then retreated by 24.94% to $2.0 million in 2025, then rose by 11.52% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $2.3 million in Q2 2026, $2.1 million in Q1 2026, and $2.0 million in Q2 2025.